The table below shows Jazz Pharmaceuticals plc's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
$408.20M
$429.80M
$267.23M
$320.71M
$208.98M
$285.00M
Capital expenditure
$19.70M
$13.90M
$6.90M
$3.82M
$12.29M
$2.17M
Investing cash flow
$123.10M
-$169.00M
-$271.90M
-$4.82M
-$37.29M
$737.13M
Dividends paid
-
-
-
-
-
JAZZ operating cash flow (10-K history)
Jazz Pharmaceuticals plc reported operating cash flow of $1.36B for fiscal year 2025. That is down 2.9% from $1.40B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $592.39M (FY 2016) to $1.36B. Figures come from the company's audited annual reports as filed with the SEC.
